New York Stock Exchange-listed pharmaceutical research and development services provider WuXi PharmaTech (Cayman) Inc. has completed a US$3.3 billion go-private deal, in which it has... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals